AREC's Portfolio Company Expands Critical & Rare Earth IP Portfolio

ReElement Technologies, a portfolio company of American Resources Corporation (AREC), filed five patent applications to broaden its chromatographic high‑purity refining platform, targeting antimony, germanium, gallium and several rare earths (terbium, gadolinium, yttrium) at purities of roughly 99.5%–99.999%; the IP expansion aims to cover both heavy and light REEs and other critical minerals used in defense, semiconductors, magnets, optics and clean‑energy technologies. The company says the patented, modular separation processes enable cleaner, lower‑capex domestic refining deployed near mines or recycling sites versus conventional solvent‑extraction, and the program is financed via a non‑dilutive royalty deal with Royalty Management Holding Corp. that grants the financier a royalty on refined output. Market context: AREC shares have gained ~153% year‑to‑date, well ahead of the industry’s ~31.5% rise, underscoring investor enthusiasm for onshore critical‑minerals processing and supply‑chain resilience.

Analysis

ReElement Technologies, an American Resources Corporation (AREC) portfolio company, has filed five patent applications to extend its proprietary chromatographic refining platform to antimony, germanium, gallium and rare earths including terbium, gadolinium and yttrium, claiming achievable purities from 99.5% up to 99.999% depending on the element. The filings explicitly target both heavy and light rare earth elements and other critical minerals used in defense systems, semiconductors, magnets, advanced optics and clean-energy technologies, positioning the technology as relevant across multiple high-value end markets.

The company frames the IP as enabling a modular, lower-capex and lower-environmental-impact domestic refining infrastructure deployable near mining, recycling or concentration sites, and this expansion is financed via a non-dilutive arrangement with Royalty Management Holding Corp., which will receive a royalty interest on refined output under the patented processes. That royalty provides upfront capital without equity dilution but creates an ongoing cost against production economics.

Market reaction appears favorable: AREC shares are up 153.4% year-to-date versus a 31.5% industry rise and the company carries a Zacks Rank #2 (Buy), reflecting investor enthusiasm. Key risks remaining in the short-to-medium term are that these are patent filings (not granted), technology commercialization and scale-up are unproven at commercial throughput, and the royalty structure may compress long-term margins if volumes underperform assumptions.

Key Decisions for Investors

• Consider selective, size-limited exposure to AREC/RElement to capture upside from improved domestic refining IP but limit position size given execution and patent-grant risk
• Prioritize monitoring near-term de-risking catalysts—patent grants, pilot plant deployment, and announced offtake or processing agreements—before increasing allocations
• Model the impact of the royalty financing on unit economics and long-term free cash flow to assess whether the non-dilutive capital materially erodes margin at projected production levels
• If currently long after the 153.4% YTD run, consider trimming into strength and re-establishing exposure on clear commercialization milestones to manage downside risk